School of Medicine
Showing 1-48 of 48 Results
Rodney U. Anderson, MD FACS
Professor (Clinical) of Urology, Emeritus
Current Research and Scholarly InterestsClinical Medical Research devoted to tertiary level application of treatment modalities for neurologic and functional disturbances of the genitourinary tract. Problems such as urinary incontinence, urinary retention, urinary flow dysfunction (BPH), impotence, and chronic pelvic pain syndromes are addressed. New medical devices and technology for treating these disorders are investigated
The Ernest and Amelia Gallo Professor, Professor of Urology, of Developmental Biology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsFunction of Hedgehog proteins and other extracellular signals in morphogenesis (pattern formation), in injury repair and regeneration (pattern maintenance). We study how the distribution of such signals is regulated in tissues, how cells perceive and respond to distinct concentrations of signals, and how such signaling pathways arose in evolution. We also study the normal roles of such signals in stem-cell physiology and their abnormal roles in the formation and expansion of cancer stem cells.
James D. Brooks
Keith and Jan Hurlbut Professor
Current Research and Scholarly InterestsWe use genomic approaches to identify disease biomarkers. We are most interested in translating biomarkers into clinical practice in urological diseases with a particular focus in cancer.
Timothy C. Chang
Clinical Assistant Professor, Urology
BioDr. Timothy Chang is a Clinical Assistant Professor of Urology at Stanford University. He graduated with High Honors from Princeton University and received a Master of Science from Massachusetts Institute of Technology. He then obtained his medical degree and urology residency training from Stanford University School of Medicine. Dr. Chang has experience in a broad range of adult general urologic care, with a particular focus on kidney stone treatment for which he completed specialized fellowship training at Stanford. He received multiple research awards and authored or co-authored numerous academic publications. With his experience in both the engineering and medical fields, he has particular interest in developing technological medical advancements.
Bertha Chen, MD
Professor of Obstetrics and Gynecology (Gynecology - Urogynecology) and, by courtesy, of Urology
Current Research and Scholarly InterestsDr. Chen’s research examines the molecular causes of urinary incontinence and pelvic floor dysfunction. Recognizing that urinary incontinence linked to demise of smooth muscle sphincter function, she is investigating the potential use of stem cell regeneration to restore muscle capacity.
Tony Chen, MD
Clinical Assistant Professor, Urology
BioDr. Chen is a fellowship-trained urologist who specializes in male reproductive medicine. He is a clinical assistant professor in the Department of Urology at Stanford University School of Medicine.
Dr. Chen diagnoses and treats male infertility, erectile dysfunction, Peyronie’s Disease, Benign Prostatic Hyperplasia (BPH), hypogonadism, and other disorders of the male genitourinary tract. He emphasizes getting to know the whole patient and utilizing a stepwise approach to treatment when appropriate. When surgery is required, he excels at scrotal surgery, minimally invasive prostate de-obstruction, penile implant placement, microsurgical vasectomy reversal, varicocele treatment, and surgical sperm retrieval.
For every patient, Dr. Chen develops a personalized care plan emphasizing innovation, safety, and compassion.
Dr. Chen has published his research findings in journals including Urology Practice, the Journal of Sexual Medicine, Endocrine, the Journal of Pediatric Urology, Journal of Endourology, and elsewhere. Topics have included the association between mortality and male infertility, the association of the COVID-19 pandemic on male sexual function, national trends in vasectomy, and more. He co-wrote the chapter “Simulation and Ureteroscopy” for the textbook Ureteroscopy.
Dr. Chen is also an innovator with an interest in bringing novel technologies to the field of benign Urology. He has a background in the use of simulation science in medical teaching as well as in prototype design. He has received grant funding to prepare robotic surgeons for acute operating room scenarios and holds a provisional patent on a system for automated urine assessment and monitoring in the hospital.
He has made presentations on male infertility and surgical simulation at meetings of the American Urological Association, American College of Surgeons, and Sexual Medicine Society.
Dr. Chen has won recognition for his research and clinical achievements. He has received awards from the Western Section of the American Urological Association, American College of Surgeons, Society of Urologic Prosthetic Surgeons, and Sexual Medicine Society of North America.
He is a member of the American Urological Association, American College of Surgeons, International Society for Sexual Medicine, American Society for Reproductive Medicine, and Western Section of the American Urological Society.
Benjamin I. Chung
Associate Professor of Urology
Current Research and Scholarly InterestsRenal cell carcinoma and prostate cancer outcomes research and epidemiology.
Craig V. Comiter
Professor of Urology and, by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly InterestsUsing various animal models of bladder outlet obstruction as a representation of human prostatic disease, I am investigating how intervening with pharmacotherapy, neuromodulation, and other novel therapies may help to reverse the adverse changes in the bladder due to the obstruction.
I also am investigating new, minimally invasive treatments for post-prostatectomy urinary incontinence.
I am also investigating the role of neruomodulation in the treatment of chronic pelvic pain and IC.
Christos E. Constantinou
Associate Professor of Urology, Emeritus
Current Research and Scholarly InterestsMy main recent interest is the application of Biomedical Engineering approaches for the clinical visualization and characterization of the static and dynamic properties of pelvic floor function. This extends to ultrasound Imaging and image processing, construction of computer models and biomechanics analysis of pelvic floor function. It is envisioned that these considerations are important constituents of the clinical evaluation of patients with lower urinary tract dysfunction and urodynamics.
Clinical Associate Professor, Urology
BioI am a founding member of the Stanford Urolithiasis Project, where we have studied population health datasets to examine surgical outcomes and environmental risk factors in urinary stone disease. Our current focus includes socioeconomic and ethnic disparities in kidney stone disease, water quality and stone disease, pregnancy in kidney stone disease and geographical variations in kidney stones incidence and metabolic kidney stone work up.
Amy D. Dobberfuhl, MD, MS
Assistant Professor of Urology
Current Research and Scholarly InterestsDr. Dobberfuhl's current clinical practice includes: Pelvic Reconstruction, Neurourology, and Voiding Dysfunction. A large proportion of Dr. Dobberfuhl's Voiding Dysfunction practice includes Bladder Pain Syndrome (BPS) and Pelvic Floor Dysfunction (PFD).
Assistant Professor of Urology and, by courtesy, of Obstetrics and Gynecology (Urogynecology)
Current Research and Scholarly InterestsRefractory overactive bladder in elderly and frail patient populations, detrusor underactivity, quality of life, patient outcomes, quality improvement, patient satisfaction, and shared decision making
Alice C. Fan
Assistant Professor of Medicine (Oncology) and, by courtesy, of Urology
Current Research and Scholarly InterestsDr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
Richard E. Fan
Clinical Assistant Professor, Urology
BioRichard E. Fan, Ph.D., is an engineer embedded in the Department of Urology in the Stanford School of Medicine.
Dr. Fan’s research relates to the development of clinically driven biomedical instrumentation and medical devices. He is interested in translational application of emerging technologies in the medical and surgical spaces, as well as the development of platforms to explore clinical and pre-clinical evaluation. His primary work is currently focused on image guided detection and treatment of prostate cancer, including MR-US fusion, focal therapies, embedded systems and robotics.
Associate Professor (Research) of UrologyOn Leave from 08/13/2022 To 08/12/2024
Current Research and Scholarly InterestsDr Fantl’s lab studies two key questions with unmet clinical need related to drug resistance and immunotherapy focusing on ovarian and kidney cancers. The lab applies multi-parametric single-cell proteomic technologies (mass cytometry aka Cytometry by Time-Of-Flight (CyTOF) and multiplex imaging (CO-Detection by indEXing (CODEX)) combined with specialized computational approaches.
Kathryn Simmons Stamey Professor
Current Research and Scholarly InterestsBenign Prostatic Hyperplasia- Evaluation and development of new minimally invasive techniques
Endourology: developing, designing and evaluating new instruments
Bladder cancer: outcomes of treatment
BPH: cryotherapy and HIFU
Clinical Assistant Professor, Urology
BioDr. Gulla is a board-certified urologist with fellowship training in endourology. She is a clinical assistant professor in the Stanford University School of Medicine Department of Urology.
For each patient, she develops a comprehensive, compassionate care plan customized to individual needs. Her goal is to help each patient achieve the best possible health and quality of life.
Dr. Gulla performs the complete spectrum of diagnostic and treatment procedures for urological conditions. She treats disorders including benign prostatic hyperplasia (BPH), blood in urine, kidney stones, male and female voiding dysfunction, neurogenic bladder, prostate cancer, and over active bladder.
She excels at ureteroscopy and cystoscopy (examination of the bladder and urinary tract with a scope), endourology (minimally invasive treatment of kidney stones), laser therapy, ultrasound-guided diagnosis and treatment, urodynamic testing, and other techniques.
To help advance her field, Dr. Gulla has conducted research. Among the topics she has investigated are voiding cystourethrogram (VCUG) testing in children for bladder and urethral abnormalities and for conditions that can lead to kidney infections.
She has presented her research findings at the national meeting of the American Urologic Association. She also has published papers in the Journal of the American College of Surgeons and elsewhere.
She is a member of the American Urologic Association.
Clinical Assistant Professor, Urology
BioDr. Kathleen Kan is a fellowship-trained pediatric urologist with a clinical practice based at LPCH and additional outreach programs in the South Bay. Her current practice includes general, endoscopic and complex reconstructive procedures and a clinical counseling interest in kidney stone disease and differences in sexual differentiation. She currently serves as the Associate Program Director of the Urology residency program.
Her current research is focused on understanding why health elementary schoolchildren develop new bladder and bowel problems.
Professor of Urology and, by courtesy, of Nephrology
Current Research and Scholarly InterestsOur research aims to improve the global quality of care for patients with Urologic Cancer with a particular focus on kidney cancer. We are investigating novel proteomic platforms and assays to diagnose kidney cancer and predict response to therapy. We are evaluating the comparative effectiveness of various kidney cancer surgeries and their impact on chronic kidney disease and its downstream effects. We are applying epidemiology, bioinformatics, and health services methods to urologic conditions.
Joseph C. Liao
Professor of Urology
Current Research and Scholarly InterestsThe overarching theme of my scholarship is to develop precision diagnostics in imaging and biomarkers to guide the delivery of precision therapy for urological diseases including bladder cancer, urinary tract infections, and kidney stone disease.
Rustin Massoudi, MD
Clinical Assistant Professor, Urology
BioDr. Massoudi is a board certified urologist specializing in general urology and urologic oncology. He is a clinical assistant professor of urology at Stanford University School of Medicine. Dr. Massoudi has expertise in treating prostate cancer, kidney cancer, kidney stones, and
enlarged prostate. He also cares for patients with bladder cancer, testicular cancer, urinary retention, and a wide range of other urologic conditions.
His experience encompasses the complete spectrum of treatment options. This includes advanced, minimally invasive techniques like endoscopy and laparoscopy, as well as robotic surgery, which can enable smaller incisions and potentially shorter recovery times. For cases where a minimally invasive approach isn’t feasible, he performs open surgery.
Dr. Massoudi partners with each patient and family to customize a treatment plan that fits their needs. He welcomes patients at all stages in their journey—from early to more advanced symptoms—and is dedicated to helping them manage their urologic health long-term. He values the rewards of helping patients through difficult times as they cope with urologic disorders.
Dr. Massoudi was drawn to urology for its unique combination of medical and surgical care, including the opportunity to use the most innovative techniques and technology. He enjoys establishing a rapport and staying in close communication with referring physicians. To ensure all of his patients receive comprehensive care, he collaborates with Stanford colleagues from endocrinology, nephrology, medical oncology, radiation oncology, and other specialties.
Building on his passion for biological sciences and bioengineering, Dr. Massoudi’s studies have included translational research into the use of proteomics to target proteins on the metabolic pathway of kidney cancer development. In partnership with the Stanford Kidney Cancer Research Program, he has also explored the role of the molecule IQGAP in kidney cancer cell migration, proliferation, differentiation, polarity, and adhesion.
While working at the Veterans Administration in Palo Alto, Dr. Massoudi collaborated on an investigation into the utility of nuclear imaging methods for identifying and staging bladder cancer. He also collaborated on research that used novel proteomic technology to understand the signaling mechanisms of renal cell carcinoma; he later performed in vitro experiments on novel biomarkers and therapeutic agents for treating it.
Dr. Massoudi has authored numerous articles on renal disorders, innovative treatment techniques and technologies, and related topics. His work has been featured in Cell, the Journal of Endourology, European Urology Oncology, Canadian Journal of Urology, American Journal of Medical Genetics, and others. He has made presentations at conferences including the American Urological Association, Society of Urology Oncology, and World Congress of Endourology.
Dr. Massoudi has received multiple honors for teaching, scholarship, and research including a Stanford Urology Teaching Award for Outstanding
Mentorship of Co-Residents. In addition, he won a Gold Humanism and Excellence in Teaching Award from Stanford University School of Medicine.
At the 43rd Annual Northern California Urological Society Conference, he won top honors for his presentation on IQGAP.
Alan C. Pao
Assistant Professor of Medicine (Nephrology) and, by courtesy, of Urology
Current Research and Scholarly InterestsWe are broadly interested in how the kidneys control salt, water, and electrolyte homeostasis in the body. Our disease focus is on kidney stone disease. We use cultured kidney cells, transgenic mice, human plasma/urine samples, and electronic health record data to study the pathogenesis of kidney stone disease. Our therapeutic focus is on the development of small molecule compounds that can be used for kidney stone prevention.
Dr. Seung-min Park
Current Research and Scholarly InterestsMy educational background and training have focused on creating micro- and nano-scale devices using newly-developed techniques and applying these processes to advance research in molecular/cellular biology. So far, my area of expertise has focused on developing methods to pattern, sort, and analyze biological materials, especially circulating tumor cells. Through my work I have created multiple Microelectromechanical System (MEMS) and Nanoelectromechanical System (NEMS) devices that can not only identify miniscule mass changes in microfluidics, but integrate mass spectrometry for molecular detection, and manipulate oligonucleotide species for sort and analysis. I am confident that my background provides the expertise in the design and fabrication of micro-/nano-scale functional modules necessary for developing next-generation devices in solving critical problems in biomedical engineering.
Christopher K. Payne, MD
Professor of Urology at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsObstetric Fistula Projects:
1. Preoperative ultrasound evaluation to detect ureteric involvement in vesicovaginal fistulas
2. Patient narrative study to identify key medical, social and economic factors that lead to fistula formation
3. Study of urinary continence after fistula repair
Pelvic pain: investigation into role of pelvic floor in chronic pelvic pain
Donna Peehl, PhD
Professor (Research) of Urology, Emerita
Current Research and Scholarly InterestsMy research focuses on the molecular and cellular biology of the human prostate. Developing realistic experimental models is a major goal, and primary cultures of prostatic epithelial and stromal cells are my main model system. Our discoveries are relevant to prevention, detection, diagnosis and treatment of benign and malignant prostatic diseases.
Paralyzed Veterans of America Professor of Spinal Cord Injury Medicine, Emeritus
Current Research and Scholarly InterestsMy major interest has been neurogenic bladder and neurogenic bowel. In other areas where I have published research include urinary tract infections , use of Laser to vaporize urethral strictures in able bodies and surgery to improve voiding in spinal cord injury patients.
Currently I am helping set up to evaluate and rehab. neurogenic bowel problems in GI Medicine at Stanford.
Kris B. Prado, MD
Assistant Professor of Urology
BioDr. Kris Prado is a urologic oncology fellowship trained surgeon-scientist, board-certified urologist, and Instructor in the Stanford University Department of Urology. His clinical practice focuses on urologic oncology, and he performs open, endoscopic, and robotic surgery. In addition to his clinical role, he is also an active member of Philip Beachy's laboratory where his research focuses on bladder urothelial development and regeneration.
Clinical Associate Professor, Obstetrics & Gynecology
Clinical Associate Professor (By courtesy), Urology
BioDr. Lisa Rogo-Gupta, MD serves as Associate Director of the Division of Gynecology and Gynecologic Specialities, Medical Director of Ambulatory Gynecology, and Well-Being Director for the department of Obstetrics and Gynecology at Stanford SOM. Dr. Rogo-Gupta proudly joined Stanford faculty in 2013, having completed residency in Obstetrics and Gynecology at Columbia University and fellowship in Female Urology and Female Pelvic Medicine and Reconstructive Surgery at the University of California, Los Angeles. During her career at Stanford she has also served as Director of OBGYN 304A for medical students interested in a career in Ob/Gyn, the Director of Urogynecology at the Pelvic Health Center, and the Director of Urogynecology resident education. In her currents roles, Dr. Rogo-Gupta seeks to incorporate physician well-being into strategic decisions impacting all parts of the academic mission--clinical care, research and education. She is particularly proud of efforts focused at improving access to gynecologic specialties care, adoption of digital health, establishing interdisciplinary team-based education, improving patient experience and physician experience in clinical efficiency. Under her leadership, ambulatory gynecology has been awarded recognition for being one of the TOP 10 patient experience drives across the Stanford Enterprise in February 2021, as well as multiple awards for exceeding patient satisfaction targets. She has received clinical teaching awards throughout her career and her research has been nationally recognized as part of the American Board of Obstetricians and Gynecologists (ABOG) annual board certification reading requirements, selected by the Journal of Urology as special interest and top articles, and appeared on the cover of Urology Practice Journal.
Dr. Rogo-Gupta has a particular clinical interest in a multi-disciplinary approach to women’s healthcare and her research interests include prolapse and incontinence surgery outcomes on both institutional and national levels, and the impact of surgical volume on outcomes. Her interests also spread outside of the US--she has travelled with the Stanford Ob/Gyn GOGYNS/GOMOMS program to Nicaragua to teach urogynecology clinical care and surgery and participated in a livestream worldwide webinar for Stanford Corporate Partners.
Assistant Professor of Radiology (Integrative Biomedical Imaging Informatics) and, by courtesy, of Urology
Current Research and Scholarly InterestsDr. Mirabela Rusu focuses on developing analytic methods for biomedical data integration, with a particular interest in radiology-pathology fusion. Such integrative methods may be applied to create comprehensive multi-scale representations of biomedical processes and pathological conditions, thus enabling their in-depth characterization.
Associate Professor of Urology
BioDr. Jay Shah, MD is a staff surgeon and associate professor of Urology at Stanford University. He is also the Cancer Care Program Leader for Urologic Oncology at the Stanford Cancer Center. He is widely respected for his work on optimizing outcomes after surgery for bladder cancer and he lectures internationally on this topic. He is a graduate of the American Urological Association Leadership Academy and he sits on multiple national AUA committees. With a deep interest in quality improvement work, Dr. Shah is the Physician Improvement Leader for the Stanford Department of Urology and a Medical Director of the Stanford Realizing Improvement Through Empowerment (RITE) Program. Since joining the Stanford faculty in February 2017, Dr. Shah has successfully completed the Clinical Effectiveness Leadership Training (CELT) Program, the Stanford Leadership Development Program, and the Stanford Medicine Leadership Academy. His vision is to have Stanford Medicine become known for instilling leadership in all of our faculty and trainees. With this goal in mind, he has started an accredited fellowship training program in Urologic Oncology and a QI/leadership training program for urology residents. He also lectures internationally on leadership development, team building, and quality improvement.
Dr. Shah graduated magna cum laude with a degree in Biological Sciences from Harvard College. He obtained his medical degree and completed his urology residency training at Columbia University. During his time at Columbia, Dr. Shah was elected to the Alpha Omega Alpha Medical Honor Society; he was named Physician of the Year by the nursing staff; and he was recognized by the medical students with the Gold Foundation Excellence in Teaching Award. After residency, he completed a three-year fellowship in Urologic Oncology at MD Anderson Cancer Center where he earned a coveted faculty position. During his time as faculty at MD Anderson, Dr. Shah launched the bladder cancer robotics program, developed an enhanced recovery program for patients undergoing bladder removal surgery, became double board-certified in Urology and Medical Quality, and was chosen to lead the MDACC Genitourinary Center as Center Medical Director.
In his free time, Dr. Shah enjoys reading, cooking, surfing, hiking and exploring the beaches of Northern California in his Jeep Wrangler with his family and 2 dogs.
Linda M. Dairiki Shortliffe
Stanley McCormick Memorial Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsThe timing for intervention in obstruction in the infant and child is poorly understood.Our group has been interested in trying to define the risks that may be involved in obstructive and infectious uropathies and discovering early signs of damage to the urinary tract and kidney. We have explored ways of imaging the urinary tract using nonionizing radiation (US, MRI). We have studied the relationships of sex steroid hormones, pregnancy, reflux, urinary tract infection and urinary tract function.
Eila C. Skinner
Thomas A. Stamey Research Professor of Urology
Current Research and Scholarly InterestsMy research focuses on outcomes in the treatment of muscle invasive and high-grade non-muscle invasive bladder cancer. This includes identifying markers of prognosis, predictive markers for response to surgery and chemotherapy, and working toward an individualized, multidisciplinary approach to disease management. I have also focused on optimizing the use of lower urinary tract reconstruction in patients undergoing cystectomy, and developing interventions to improve patient quality of life.
Eric R. Sokol, MD
Associate Professor of Obstetrics and Gynecology (Gynecology-Urogynecology) and, by courtesy, of Urology
Current Research and Scholarly InterestsMy research is focused on the development and testing of novel minimally invasive treatment modalities for complex pelvic floor disorders.
Associate Professor of Urology and, by courtesy, of Radiology (Body MRI)
Current Research and Scholarly InterestsMy interest is in improving prostate cancer diagnosis through MRI and image-targeted prostate biopsy. In collaboration with radiologists at Stanford, we are working to define the optimal role of MRI in prostate cancer. We hope to improve cancer imaging to the point that some men with elevated PSA may safely avoid prostate biopsy. For those who need biopsy, we are evaluating novel MRI-US fusion targeted biopsy, a technique that greatly improves upon the conventional biopsy method.
Professor of Medicine (Oncology) and, by courtesy, of Urology
Current Research and Scholarly InterestsClinical interests: general oncology, genito-urinary malignancy Research interests: conducting clinical trials in advanced prostate cancer, bladder cancer and renal cell carcinoma
Leslee L.Subak, MD
Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor, by courtesy, of Urology
Current Research and Scholarly InterestsMy research focuses on the association of weight and urinary incontinence (UI) in women and clinical trials to test strategies to improve outcomes in women’s genitourinary health. We have shown the independent association of weight and UI and the efficacy of weight loss to treat women with UI. I also conduct studies of epidemiology, economics and cost-effectiveness, and novel interventions for UI, sexual dysfunction, vaginal atrophy, pelvic organ prolapse and menopause symptoms.
Professor of Urology, Emeritus
Current Research and Scholarly InterestsWe focus on understanding the molecular mechanism of transcription factors that govern the transformation of normal cells to a neoplastic state. We are especially interested in nuclear hormone action and its interactions with other signaling pathways in tumor development and progression.
Alan Eih Chih Thong
Clinical Assistant Professor, Urology
BioDr. Thong is a surgeon specializing in urologic oncology. He has expertise in all aspects of prostate, kidney, bladder, and testicular cancer care, including endoscopic, robotic, and open surgery, and has a special interest in complex cases including: salvage surgery following radiation or chemotherapy, resection of locally advanced tumors, minimal access robotic surgery, and MRI-US fusion targeted biopsies. Dr. Thong is the first surgeon in northern California to utilize single port robotic assisted laparoscopic technology for both pelvic and retroperitoneal surgeries. He has won numerous awards including the NIH Ruth L. Kirschstein National Research Service Award, and has authored and co-authored publications on the treatment of urologic cancers.